Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Am J Cardiol. 2015 Jun 3;116(5):686–693. doi: 10.1016/j.amjcard.2015.05.036

Table 2.

Clinical outcomes and temporal trends.

Event Rate
Event Overall 0–30 days Month 1–12 12 month – 4 year
ISCHEMIC ENDPOINT
Cardiovascular death, non-periprocedural myocardial infarction or definite/probable stent thrombosis 1.64%/yr
0.14%/mo
(6.51%)*
10.76%/yr
0.90%/mo
(0.89%)*
1.42%/yr
0.12%/mo
(1.29%)*
1.44%/yr
0.12%/mo
(4.40%)*
 Cardiovascular death 0.91%/yr
0.08%/mo
(3.69%)
5.24%/yr
0.44%/mo
(0.44%)*
0.82%/yr
0.07%/mo
(0.75%)*
0.88%/yr
0.07%/mo
(2.72%)*
 Non-periprocedural myocardial infarction 0.87%/yr
0.07%/mo
(3.52%)*
5.24%/yr
0.44%/mo
(0.44%)*
1.10%/yr
0.09%/mo
(1.00%)*
0.69%/yr
0.06%/mo
(2.11%)*
 Definite/probable stent thrombosis 0.51%/yr
0.04%/mo
(2.06%)*
 Acute 34.45%/yr
2.87%/mo
(0.10%)*
N/A N/A
 Subacute 8.47%/yr
0.71%/mo
(0.68%)*
N/A N/A
 Late N/A 0.31%/yr
0.03%/mo
(0.29%)*
N/A
 Very late N/A N/A 0.37%/yr
0.03%/mo
(1.14%)*
BLEEDING ENDPOINT
GUSTO Moderate/Severe bleeding 0.75%/yr
0.06%/mo
(3.03%)*
8.19%/yr
0.68%/mo
(0.68%)*
1.08%/yr
0.09%/mo
(0.98%)*
0.44%/yr
0.04%/mo
(1.36%)*
 Moderate 0.40%/yr
0.03%/mo
(1.64%)*
2.94%/yr
0.24%/mo
(0.24%)*
0.64%/yr
0.05%/mo
(0.59%)*
0.26%/yr
0.02%/mo
(0.82%)*
 Severe 0.34%/yr
0.03%/mo
(1.39%)*
5.24%/yr
0.44%/mo
(0.44%)*
0.57%/yr
0.05%/mo
(0.52%)*
0.17%/yr
0.01%/mo
(0.54%)*
*

Absolute rate